Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/1390
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Parker, D. | - |
dc.contributor.author | Marino, V. | - |
dc.contributor.author | Ivar, P. | - |
dc.contributor.author | de la Lande, I. | - |
dc.date.issued | 1998 | - |
dc.identifier.citation | Archives of Oral Biology, 1998; 43(12):949-954 | - |
dc.identifier.issn | 0003-9969 | - |
dc.identifier.issn | 1879-1506 | - |
dc.identifier.uri | http://hdl.handle.net/2440/1390 | - |
dc.description.abstract | This study was undertaken to test for the presence of presynaptic beta-adrenoceptors on sympathetic nerves in human dental pulp and, if present, to investigate the subtype. Pulp was excised from freshly extracted teeth, incubated with [3H]-noradrenaline (0.6 micromol/l) and subsequently superfused with Krebs solution. Sympathetic nerves were stimulated at 5 Hz for 100 sec. The non-specific beta-adrenoceptor agonist isoprenaline (1.0 micromol/l), and the selective beta2-agonist salbutamol (10 micromol/l) facilitated the release of [3H]-noradrenaline; isoprenaline, but not salbutamol, also facilitated this release in the presence of desipramine (DMI, 0.3 micromol/l), corticosterone (10 micromol/l) and rauwolscine (0.1 micromol/l). BRL 37344 (1.0 micromol/l), a beta3-agonist, had no effect on [3H]-noradrenaline release. The facilitatory effects of isoprenaline and salbutamol were inhibited by the non-specific beta-antagonist propranolol (1.0 micromol/l), while that of salbutamol was inhibited in the presence of ICI-188,551 (1.0 micromol/l), a selective beta2-antagonist, as well. The beta1-antagonist atenolol (1.0 micromol/l) potentiated the facilitatory effects of isoprenaline in the presence of DMI and corticosterone. Neither propranolol nor ICI-188,551 alone affected the release of [3H]-noradrenaline. These results establish the presence of presynaptic beta-adrenoceptors on sympathetic nerves in human dental pulp. It is suggested that they are of the beta2-subtype, although a greater range of agonists and antagonists needs to be used to clarify the nature of the the beta-adrenoceptors. | - |
dc.description.statementofresponsibility | D.A.S Parker, V Marino, P.M Ivar, I.S de la Lande | - |
dc.language.iso | en | - |
dc.publisher | Pergamon | - |
dc.rights | © 1998 Elsevier Science Ltd. All rights reserved. | - |
dc.source.uri | http://dx.doi.org/10.1016/s0003-9969(98)00087-9 | - |
dc.subject | Human dental pulp | - |
dc.subject | sympathetic nerves | - |
dc.subject | presynaptic β-receptors | - |
dc.subject | isoprenaline | - |
dc.subject | propranolol | - |
dc.subject | salbutamol | - |
dc.subject | atenolol | - |
dc.title | Modulation by presynaptic β-adrenoceptors of noradrenaline release from sympathetic nerves in human dental pulp | - |
dc.title.alternative | Modulation by presynaptic beta-adrenoceptors of noradrenaline release from sympathetic nerves in human dental pulp | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/S0003-9969(98)00087-9 | - |
pubs.publication-status | Published | - |
Appears in Collections: | Aurora harvest 2 Dentistry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.